Lv11
90 积分 2023-08-17 加入
HMPL-306 in relapsed or refractory IDH1- and/or IDH2-mutated acute myeloid leukemia: A phase 1 study
3小时前
待确认
Discovery of HMPL-306 (Ranosidenib), a New Potent and Selective Dual Inhibitor of Mutant IDH1 and 2 in Clinical Development for Cancer Treatment
6小时前
已完结
Legumain-Cleavable Top1i Antibody-Drug Conjugates without Self-Immolative Spacers Demonstrate Potent Antitumor Activity
4天前
已完结
Enhancing SN38 prodrug delivery using a self-immolative linker and endogenous albumin transport
8天前
已完结
Albubody: an engineered scFv variant platform for site-specific drug conjugation and enhanced tumor efficacy
8天前
已完结
Mechanistic Insights of a p53-Targeting Small Molecule
17天前
已完结
Overcoming cancer therapy resistance: From drug innovation to therapeutics
27天前
已完结
Impact of endogenous vasohibin 1 and vasohibin 2 gene expression on ferroptosis in a mouse cerebral infarction model
28天前
已完结
Drug–drug conjugates of MEK and Akt inhibitors for RAS-mutant cancers
1个月前
已完结
ESCRTs – a multi-purpose membrane remodeling device encoded in all life forms
1个月前
已完结
皖公网安备34019202002308
